ISOO/MASCC Risk of Secondary Oral Cancer Following Hematopoietic Cell Transplantation Guideline Summary - Guideline Central
Clinical relevance and practical considerations
Document Overview

Risk of Secondary Oral Cancer Following Hematopoietic Cell Transplantation

Multinational Association of Supportive Care in Cancer

International Society of Oral Oncology


Publication Date: Jul 25, 2024

Page Last Updated: May 5, 2026



Document Overview

Document Title
Risk of Secondary Oral Cancer Following Hematopoietic Cell Transplantation
Authoring Societies

Multinational Association of Supportive Care in Cancer

International Society of Oral Oncology

Document Publication Date
Jul 25, 2024
Page Last Reviewed/Updated
May 5, 2026
Document Type
Consensus Statement
Country of Publication
Global
Full Text Freely Available
Yes
Full Text Guideline
link.springer.com/article/10.1007/s00520-024-08685-y
Source Citation

Raber-Durlacher JE, Treister NS, Zadik Y, Dean DR, Miranda-Silva W, Fregnani ER, Epstein JB, Elad S. MASCC/ISOO Clinical Practice Statement: The risk of secondary oral cancer following hematopoietic cell transplantation. Support Care Cancer. 2024 Jul 25;32(8):545. doi: 10.1007/s00520-024-08685-y. PMID: 39048762; PMCID: PMC11269467.


Document Scope, Criteria, and Use Cases

Document Objectives

A MASCC/ISOO Clinical Practice Statement (CPS) is aimed at generating a concise tool for clinicians that concentrates practical information needed for the management of oral complications of cancer patients. This CPS is focused on the risk of secondary oral cancer following hematopoietic cell transplantation (HCT).

Scope
Management, Prevention
Diseases/Conditions (MeSH)

D018380 - Hematopoietic Stem Cell Transplantation

D018380 - Hematopoietic Stem Cell Transplantation

Keywords
Hematopoietic cell transplantation, oral cancer
Inclusion Criteria
Male, Female, Adult, Older Adult
Health Care Settings
Ambulatory, Outpatient
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resource
Methodology Supplement
Number of Source Documents
19
Includes peer/external review process?
Yes
Includes public comment process?
Yes
Methodologist involvement?
Yes
Patient involvement?
No
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
No
Grades quality of strength of recommendation?
No
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
Yes
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.